VEEV's Quality Score rose 1 point on Fri, Oct 30, to 19. Had its narrowest day in a week.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
3% under its Oct 23, 2026 high.
“The increase in subscription revenues consisted of $247 million attributable to R&D and Quality Solutions and $153 million attributable to Commercial Solutions.”
| The company | Profit nearly doubled |
| Its score | Up:Excellent or better for 20 days in a row |
| Latest filing | 10-Q, Aug 27 |
After its last 4 reports it closed +2.3% on average, higher 2 of 4 times.
Excellentfor quality, not price, 7 of 14 chart checks firingWhat the Quality Score means
VEEV is #4 of 271 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 4 |
Net income over four quarters: VEEV $1.01B, ORCL $18.9B, CRM $9.66B, NOW $1.67B.
Expected to report Wed Nov 25, after the close (in 23 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 26, 2026 | +12.4% | +15.2% | +14.6% |
| Jun 3, 2026 | +2.3% | -0.1% | -8.4% |
| Mar 4, 2026 | +6.9% | +4.0% | -0.7% |
Sales grew every year from 2019 to 2026, to $3.2B. It made a profit in each of the eight years.
2 insiders sold $1.5M across 3 filings in the last 6 months. No open-market buys on record. The newest:
12 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: VEEV is 0.2% of SCHG, under 0.1% of VOO, and under 0.1% of IVV, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Aug 31, 2026.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
“The markets for our solutions are global, rapidly evolving, highly competitive, and subject to changing regulations, advancing technology, and shifting customer needs.”
VEEV scores 19 today, which Breakaway calls Excellent. It is #4 of 271 in Software by Quality Score, with 7 of 14 chart checks firing. 3% under its Oct 23, 2026 high. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
VEEV scores 19 today, which Breakaway calls Excellent (15 to 19). That is #4 of 271 in Software by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind VEEV's 19.
2 insiders sold $1.5M across 3 filings in the last 6 months. No open-market buys on record. The newest is Daniel J. Rizzo, EVP, Sales, Consulting, & Svcs, who sold $1.2M on Oct 2. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.